MedPath

An Evaluation of a Gender Specific Insole to Provide Relief From Knee Pain Due to Osteoarthritis or General Anterior Knee Pain in Male Subjects When Used in Foot Wear Over a Period of Four Weeks

Not Applicable
Completed
Conditions
Osteoarthritis, Knee
Interventions
Device: BPI 1000013 (Dr Scholls Insole)
Registration Number
NCT03556787
Lead Sponsor
Bayer
Brief Summary

The primary objective of this trial is to demonstrate the ability of a full length foam insole to provide relief from pain due to osteoarthritis of the knee or general knee pain when used in foot wear for a 4-week period of time.

The secondary objectives comprise the evaluation of the insole's ability to provide appropriate shoe fit and comfort as well as relief from osteoarthritis/ general knee pain after short-term use. The safety and tolerability of the test articles in terms of adverse events (AE) will also be investigated.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Male
Target Recruitment
89
Inclusion Criteria
  • Male subjects with age 18 to 70 years and a self-reported foot size between 8 and 14
  • Subjects with regular knee pain
  • Subjects with a baseline pain level of pain of ≥20 mm to ≤90 mm on 100 mm VAS scale at baseline (Visit 1)
  • Subjects must be able to walk unaided by cane or walker.
Read More
Exclusion Criteria
  • Subjects with knee pain which is due to a recent injury
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients with knee painBPI 1000013 (Dr Scholls Insole)Adults patients suffering from osteoarthritis pain or general knee pain
Primary Outcome Measures
NameTimeMethod
Osteoarthritis knee pain according to Visual Analog ScaleUp to 4 weeks

100 mm Visual Analog Scale: 0 = no pain to 100 = worst pain possible

General anterior knee pain according to Visual Analog ScaleUp to 4 weeks

100 mm Visual Analog Scale: 0 = no pain to 100 = worst pain possible

Secondary Outcome Measures
NameTimeMethod
Foot Comfort according to Likert scaleUp to 4 weeks

7-point Comfort/ Discomfort Likert scale, ranging from 1 = Extreme Discomfort to 7 = Extreme Comfort

Number of subjects with serious adverse eventsUp to 4 weeks
Shoe Fit according to Likert scaleUp to 4 weeks

7-point Comfort/ Discomfort Likert scale, ranging from -3 = Much too loose fit to 3 = Much too tight fit

Number of subjects with adverse eventsUp to 4 weeks

Trial Locations

Locations (2)

Focus & Testing, Inc.

🇺🇸

Calabasas, California, United States

The Wolf Group

🇺🇸

Cincinnati, Ohio, United States

© Copyright 2025. All Rights Reserved by MedPath